Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jul;21(3):505-18.
doi: 10.1128/CMR.00055-07.

Host-pathogen interactions in Campylobacter infections: the host perspective

Affiliations
Review

Host-pathogen interactions in Campylobacter infections: the host perspective

Riny Janssen et al. Clin Microbiol Rev. 2008 Jul.

Abstract

Campylobacter is a major cause of acute bacterial diarrhea in humans worldwide. This study was aimed at summarizing the current understanding of host mechanisms involved in the defense against Campylobacter by evaluating data available from three sources: (i) epidemiological observations, (ii) observations of patients, and (iii) experimental observations including observations of animal models and human volunteer studies. Analysis of available data clearly indicates that an effective immune system is crucial for the host defense against Campylobacter infection. Innate, cell-mediated, and humoral immune responses are induced during Campylobacter infection, but the relative importance of these mechanisms in conferring protective immunity against reinfection is unclear. Frequent exposure to Campylobacter does lead to the induction of short-term protection against disease but most probably not against colonization. Recent progress in the development of more suitable animal models for studying Campylobacter infection has opened up possibilities to study the importance of innate and adaptive immunity during infection and in protection against reinfection. In addition, advances in genomics and proteomics technologies will enable more detailed molecular studies. Such studies combined with better integration of host and pathogen research driven by epidemiological findings may truly advance our understanding of Campylobacter infection in humans.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Total number of confirmed Campylobacter cases in the European Union until 2003. Data after 2003 are not shown because several new European Union (EU) member states with a high reported incidence of campylobacteriosis joined the European Union (Table 1).
FIG. 2.
FIG. 2.
Schematic representation of host-pathogen interactions in campylobacteriosis. Pathogen-host encounters in a certain environment can either lead to infection or not. Infected individuals can then remain asymptomatic or go on to develop disease. To what extent this leads to the induction of protective immunity is currently unknown.

References

    1. Abuoun, M., G. Manning, S. A. Cawthraw, A. Ridley, I. H. Ahmed, T. M. Wassenaar, and D. G. Newell. 2005. Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infect. Immun. 73:3053-3062. - PMC - PubMed
    1. Al Salloom, F. S., A. Al Mahmeed, A. Ismaeel, G. A. Botta, and M. Bakhiet. 2003. Campylobacter-stimulated INT407 cells produce dissociated cytokine profiles. J. Infect. 47:217-224. - PubMed
    1. Altekruse, S. F., N. J. Stern, P. I. Fields, and D. L. Swerdlow. 1999. Campylobacter jejuni—an emerging foodborne pathogen. Emerg. Infect. Dis. 5:28-35. - PMC - PubMed
    1. Anders, B. J., B. A. Lauer, J. W. Paisley, and L. B. Reller. 1982. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet i:131-132. - PubMed
    1. Andersen-Nissen, E., K. D. Smith, K. L. Strobe, S. L. Barrett, B. T. Cookson, S. M. Logan, and A. Aderem. 2005. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. USA 102:9247-9252. - PMC - PubMed

Publication types

MeSH terms

Substances